Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3%
4 days ago · Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...
Why Pfizer sold its $3 billion stake in Haleon | Invezz
5 days ago · Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale - Yahoo …
6 days ago · Pfizer sold shares of Haleon last year, including a £2.4 billion overnight sale in the autumn. Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units.
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
6 days ago · (Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner ...
Pfizer Provides Update on Ownership Interest in Haleon
Jun 1, 2022 · However, in keeping with Pfizer’s transformation into a more focused, global leader in science-based innovative medicines and vaccines, the company intends to exit its 32% ownership interest in Haleon in a disciplined manner, with the objective of maximizing value for Pfizer shareholders.
Pfizer to Cut Haleon Stake - Morningstar
6 days ago · The move is expected to reduce Pfizer's stake to about 7.3% of Haleon's issued ordinary shares with voting rights from approximately 15%. Pfizer will receive all of the net proceeds, while Haleon ...
Pfizer to cut Haleon stake in 700M share sale - Seeking Alpha
6 days ago · Pfizer (NYSE:PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon (NYSE:HLN) to lower its stake in the British consumer healthcare giant from about 15.0% to 7.3% ...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale (2)
6 days ago · Pfizer Inc. sold about 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne toothpaste. The deal raised around £2.5 billion ($3.1 billion) for the seller, which offered the shares through an accelerated placement with investors, according to terms seen by Bloomberg.
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Sep 30, 2024 · Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil...
Pfizer Provides Update on Ownership Interest in Haleon
Jun 1, 2022 · Following the demerger and listing of Haleon on the London Stock Exchange (LSE), which is expected to occur in July 2022, Pfizer will continue to hold a 32% ownership interest in Haleon.